Endocrinology, Vol 136, 2074-2081, Copyright © 1995 by Endocrine Society

ARTICLES

Early detection of secretogranin-II (SgII) in the human fetal pituitary: immunocytochemical study using an antiserum raised against a human recombinant SgII

VS Vallet, B Griffond, MC Clavequin, M de Monti, D Fellmann and J Duval
Centre National de la Recherche Scientifique URA-256 Biologie Cellulaire et Reproduction, Universite de Rennes I, France.

Secretogranin-II (SgII) is a protein contained within secretory granules of mainly gonadotrophs. The purpose of this study was to determine whether SgII immunoreactivity (SgII-IR) in the human fetal pituitary was temporally related to gonadotropin immunoreactivity. A specific antihuman SgII antiserum was thus required. A complementary DNA clone with an open reading frame for human (h) SgII was synthesized by reverse transcription-polymerase chain reaction from pituitary total RNA. This clone was used to obtain the SgII polypeptide (-9 to 152) as a fusion protein, in a heterologous expression prokaryotic system. Antisera against the fusion protein were raised in rabbits and checked for specificity and sensitivity through Western blotting. Human fetal pituitaries from week 6 of gestation onward were used for immunocytochemical studies. Consecutive semithin sections were treated with the specific antisera against hSgII, beta-endorphin, and hPRL and with monoclonal antibodies to hCG alpha, hLH, and hFSH. SgII immunoreactivity appeared at week 8 and was restricted to pituitary cells expressing beta-endorphin (100% colocalization). At week 9, FSH- positive cells did not contain SgII. From week 10, gonadotrophs progressively exhibited SgII-IR, up to 50% of that in FSH-containing cells at week 26. The granin was never found in PRL cells whatever the stage of development. The present data demonstrate that SgII-IR is detected very early in fetal life; however, the positive cells are not gonadotrophs, but corticotrophs. Within gonadotrophs, SgII appears subsequent to hormones. At birth, more than 90% of SgII-IR cells are represented by corticotrophs and gonadotrophs.

This article has been cited by other articles:

				J. R. Peinado, R. Vazquez-Martinez, D. Cruz-Garcia, A. Ruiz-Navarro, Y. Anouar, M. C. Tonon, H. Vaudry, F. Gracia-Navarro, J. P. Castano, and M. M. Malagon Differential Expression and Processing of Chromogranin A and Secretogranin II in Relation to the Secretory Status of Endocrine Cells Endocrinology, March 1, 2006; 147(3): 1408 - 1418. [Abstract] [Full Text] [PDF]

				Y. Anouar, C. Desmoucelles, L. Yon, J. Leprince, L. Breault, N. Gallo-Payet, and H. Vaudry Identification of a Novel Secretogranin II-Derived Peptide (SgII187-252) in Adult and Fetal Human Adrenal Glands Using Antibodies Raised against the Human Recombinant Peptide J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2944 - 2951. [Abstract] [Full Text]

				L. C. Jones and J. G. Scammell The cAMP-response element mediates induction of secretogranin II by CHX and FSK in GH4C1 cells Am J Physiol Endocrinol Metab, April 1, 1998; 274(4): E656 - E664. [Abstract] [Full Text] [PDF]